98534-84-0

Usage

Uses

Used in Pharmaceutical Industry:
1-(4-METHYLPHENYL)-5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOLE-3-THIOL is used as a potential candidate for drug development due to its antimicrobial, anticancer, and anti-inflammatory properties. Its unique structure and properties make it an interesting compound for further research and potential commercial use in the pharmaceutical industry.
Used in Agrochemical Industry:
In the agrochemical industry, 1-(4-METHYLPHENYL)-5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOLE-3-THIOL is used for its potential applications in developing new compounds with pesticidal, herbicidal, or fungicidal properties. Its diverse biological activities make it a promising candidate for creating innovative solutions to combat various agricultural challenges.
Used in Research and Development:
1-(4-METHYLPHENYL)-5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOLE-3-THIOL is also used in research and development for exploring its potential in various scientific fields. Its unique structure and properties make it an interesting subject for further investigation, which could lead to the discovery of new applications and uses in different industries.

InChI:InChI=1/C12H9F3N2O2/c1-7-2-4-8(5-3-7)17-10(12(13,14)15)9(6-16-17)11(18)19/h2-6H,1H3,(H,18,19)

Upstream product

• 539-44-6 N-4-methylphenylhydrazine 

Relevant academic research and scientific papers

Synthesis, Biological Evaluation, and 3D-QSAR Studies of N-(Substituted pyridine-4-yl)-1-(substituted phenyl)-5-trifluoromethyl-1 H-pyrazole-4-carboxamide Derivatives as Potential Succinate Dehydrogenase Inhibitors

A series of new fungicides that can inhibit the succinate dehydrogenase (SDH) was classified and named as SDH inhibitors by the Fungicide Resistance Action Committee in 2009. To develop more potential SDH inhibitors, we designed and synthesized a novel se

SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONISTS

Disclosed are compounds of Formula (I), or a stereoisomer or a pharmaceutically acceptable salt thereof, wherein: A is formula (II) Q is a substituted 5-membered monocyclic heteroaryl group; W is CH2, O, or NH; and R1, R2, R3, R4, R5, R6, m, n, t, and x are defined herein. Also disclosed are methods of using such compounds as selective agonists for G protein-coupled receptor S1P1, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.

Pyrazole-amides and sulfonamides as sodium channel modulators

Compounds of the present invention modulate PN3 in mammals and are useful in treating pain in mammals.

Pyrazole-amides and sulfonamides as sodium channel modulators

Compounds of the present invention modulate PN3 in mammals and are useful in treating pain in mammals.